Skip to content

A Strategy for Gallstone Expulsion Through Dietary Therapy

A New Strategy for Gallstone Expulsion Through Dietary Therapy: A Prospective, Single-Center, Double-Blind, Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06699030
Enrollment
100
Registered
2024-11-21
Start date
2024-12-24
Completion date
2026-12-01
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Stone

Keywords

Gallstone, Gallbladder Function, Cholecystitis, Ultrasound Examination

Brief summary

This study is a double-blind, prospective, single-center controlled trial conducted at a tertiary hospital, aiming to determine whether dietary therapy can effectively expel gallstones.

Detailed description

Gallstones are a common clinical condition, and their prevalence has been increasing globally in recent years. Gallstone formation is a result of various combined factors, and in its early stages, gallstones often exist in a sludge-like form. Currently, there is no definitive research on whether gallbladder sludge can be effectively expelled through medication or dietary therapy. Therefore, the investigators are conducting a double-blind, prospective, single-center controlled trial to verify whether gallbladder sludge-like stones can be effectively expelled using dietary therapy.

Interventions

DRUGFunctional fatty acids

Days 1-3: Oral Administration of functional fatty acids Days 4-6: Oral Administration of functional fatty acids

OTHERPlacebo

Days 1-3: Placebo Days 4-6: Oral Administration of functional fatty acids

Sponsors

Hepatopancreatobiliary Surgery Institute of Gansu Province
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double (Investigator, Participant)

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm

Exclusion criteria

* History of ERCP (Endoscopic Retrograde Cholangiopancreatography) * Previous gallstone removal surgery with gallbladder preservation * History of acute or chronic pancreatitis, cholangitis * Mirizzi Syndrome * History of gastrointestinal surgery * Gastrointestinal obstruction * Dysfunction of the sphincter of Oddi * Gallbladder neck polyps * Abnormal gallbladder structure * Gallbladder mass * Biliary infection or stones * Congenital biliary abnormalities * Biliary injury or surgery * Biliary tumors * Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases * Significant arrhythmia, bradycardia, or atrioventricular block * Severe hypertension, liver or kidney insufficiency * Immune, endocrine, hematological, or mental disorders * Severe cerebrovascular disease * Allergy to relevant foods * Pregnant or breastfeeding women * Unwillingness or inability to consent to participation

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with complete expulsion of gallbladder sludge after three days of intervention7 daysDetermined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled
2)Number of patients with complete expulsion of gallbladder sludge after six days of intervention7 daysDetermined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled

Secondary

MeasureTime frameDescription
Serum bilirubin7 daysDetermined by lab examination within 3.4-17.1μmol/L
Presence of Abdominal Pain Post-Intervention7 daysIf abdominal pain is present, it will be assessed using the Numerical Rating Scale (NRS) within 0-10, The higher the score, the more serious it is
Gallbladder Volume7 daysMeasured by ultrasound (L × W × D × 0.52)
Occurrence of Gastrointestinal Bleeding Post-Intervention14 daysBlack stool or decrease of HB
Nausea, Vomiting, and Diarrhea Post-Intervention14 daysFrequency of Nausea, Vomiting, and Diarrhea Post-Intervention
Occurrence of Acute Pancreatitis Post-Intervention14 daysPain and Amy \>3times as normal
Gallbladder Wall Thickness7 daysMeasured by ultrasound, accurate to 0.1 mm

Countries

China

Contacts

Primary ContactWenbo Meng, M.D.
mengwb@lzu.edu.cn13919177177
Backup ContactLong Deng, M.D.
ldyy_longdengld@lzu.edu.cn13893192432

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 5, 2026